REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,366,436 | +258.4% | 53,988 | +356.1% | 0.20% | +288.5% |
| Q1 2023 | $381,302 | -43.0% | 11,838 | -67.3% | 0.05% | -45.3% |
| Q4 2022 | $669,175 | +187.2% | 36,250 | +360.8% | 0.10% | +131.7% |
| Q2 2021 | $233,000 | -64.6% | 7,866 | -70.0% | 0.04% | -51.2% |
| Q3 2020 | $659,000 | +137.9% | 26,199 | +130.6% | 0.08% | +133.3% |
| Q2 2020 | $277,000 | +136.8% | 11,360 | +43.5% | 0.04% | +125.0% |
| Q1 2020 | $117,000 | -22.0% | 7,918 | -14.1% | 0.02% | -36.0% |
| Q4 2019 | $150,000 | – | 9,213 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |